NK

Noriko Koizumi

TD The Doshisha: 15 patents #1 of 175Top 1%
SC Senju Pharmaceutical Co.: 12 patents #8 of 231Top 4%
KU Kyoto Prefectural Public University: 11 patents #2 of 137Top 2%
UN Unknown: 4 patents #4,220 of 83,584Top 6%
JC Jcr Pharmaceuticals Co.: 2 patents #36 of 149Top 25%
CO Corneagen: 2 patents #6 of 15Top 40%
AB Aurion Biotech: 1 patents #5 of 12Top 45%
Overall (All Time): #168,820 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
12343356 mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof Naoki Okumura 2025-07-01
12072334 Corneal endothelial cell marker Naoki Okumura, Hiroatsu Hirano, Shigeru Kinoshita, Morio Ueno 2024-08-27
11918630 Treatment of retina and nerve using laminin Naoki Okumura, Shigeru Kinoshita 2024-03-05
11857544 Composition or method including (t)ew-7197 for treating or preventing corneal endothelial diseases Naoki Okumura, Mayumi Yamamoto 2024-01-02
11839618 Agent for promoting corneal endothelial cell adhesion Shigeru Kinoshita, Morio Ueno 2023-12-12
11730722 Corneal endothelium ECM therapeutic medicaments Naoki Okumura, Shigeru Kinoshita 2023-08-22
11633404 Agent for promoting corneal endothelial cell adhesion Shigeru Kinoshita, Morio Ueno 2023-04-25
11633477 Treatment of cornea using laminin Naoki Okumura, Shigeru Kinoshita 2023-04-25
11624053 Application of laminin to corneal endothelial cell culture Naoki Okumura, Shigeru Kinoshita, Friedrich E. KRUSE, Ursula Schloetzer-Schrehardt 2023-04-11
11576914 Drug for treating or preventing disorder caused by TGF-β signaling, and application thereof Naoki Okumura 2023-02-14
11445723 Method and container for preserving corneal endothelial cells Naoki Okumura 2022-09-20
11446263 Caspase inhibitor-containing drug for treating or preventing disorders caused by TGF-β, and applications thereof Naoki Okumura 2022-09-20
11433090 mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof Naoki Okumura 2022-09-06
11382904 Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endothelium Naoki Okumura, Shigeru Kinoshita 2022-07-12
10980787 Drug for treating or preventing disorder caused by TGF-B signals, and application thereof Naoki Okumura 2021-04-20
10959997 Combined agent for cell therapy of corneal endothelial cell Naoki Okumura, Shigeru Kinoshita 2021-03-30
10908161 Corneal endothelial cell marker Naoki Okumura, Hiroatsu Hirano, Shigeru Kinoshita, Morio Ueno 2021-02-02
10813920 Drug for treating corneal endothelium by promoting cell proliferation or inhibiting cell damage Naoki Okumura, Shigeru Kinoshita 2020-10-27
10335439 Method for producing human corneal epithelium sheet Kiwamu Imagawa, Kenichi Maeda, Yuki HOSODA, Shuichi Yokoyama, Naoki Okumura +1 more 2019-07-02
10174284 Medium, for culturing corneal endothelial cells, containing conditioned medium from mesenchymal stem cells Michio Hagiya, Kiwamu Imagawa, Yuuki Hosoda, Naoki Okumura, Makiko Nakahara +1 more 2019-01-08
10052411 Methods of treating corneal related diseases by corneal endothelial preparation which enables cells to grow in vivo Shigeru Kinoshita, Yuji Sakamoto 2018-08-21
9616101 Differentiation marker and differentiation control of eye cell Takahiro Nakamura, Naoki Okumura, Shigeru Kinoshita, Kana Tominaga, Satoshi Kawasaki 2017-04-11
9248125 Agent for promoting corneal endothelial cell adhesion Shigeru Kinoshita, Morio Ueno 2016-02-02
8895508 Methods for corneal endothelial proliferation using bFGF sustained-release gelatin hydrogel particles Yasuhiko Tabata, Shigeru Kinoshita, Yuji Sakamoto, Naoki Okumura, Hiroaki Takahashi 2014-11-25